Data / Form D filings / Sensorium Therapeutics, Inc.
Sensorium Therapeutics, Inc.: Form D filings
Sensorium Therapeutics, Inc., a pharmaceuticals company in Medford, MA, filed 5 Form D notices with the SEC between 2021 and 2025. The latest, on July 15, 2025, reports $26.8 million sold of a $58.5 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 47 HIGH ST. #513, Medford, MA, 02155
- Phone
- (339) 329-2333
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1874823
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 15, 2025 | Amendment | $58,496,525 | $26,763,207 | $31,733,318 | 19 | Jan 28, 2025 | sec.gov |
| Feb 12, 2025 | New notice | $38,496,525 | $14,496,526 | $23,999,999 | 4 | Jan 28, 2025 | sec.gov |
| Dec 6, 2023 | Amendment | $24,789,809 | $24,689,802 | $100,007 | 64 | Sep 19, 2022 | sec.gov |
| Oct 4, 2022 | New notice | $24,789,809 | $15,512,569 | $9,277,240 | 46 | Sep 19, 2022 | sec.gov |
| Jul 23, 2021 | New notice | $9,000,000 | $9,000,000 | 47 | Jul 8, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jerrold Rosenbaum | Director | |
| Ryan Katz | Director | |
| Kevin Lalande | Director | |
| Richard Simon | Director | |
| Balkrishan Gill | Director | |
| Alexandra Glucksmann | Director | |
| Jacob Hooker | Executive Officer, Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jul 14, 2025 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sensorium Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.